Ion Beam Applications S.A. | Ownership
Companies that own Ion Beam Applications S.A.
CAPFI DELEN Asset Management SA
1,920,265
6.4%
367,614
0.2%
12/31/2017
Kempen Capital Management NV
875,388
2.92%
-24,786
0.41%
04/13/2018
Norges Bank Investment Management
859,382
2.87%
0
0%
02/08/2018
Kempen Capital Management (UK) Ltd.
593,862
1.98%
-22,023
2.15%
07/31/2018
The Vanguard Group, Inc.
485,895
1.62%
-106
0%
07/31/2018
Henderson Global Investors Ltd.
425,038
1.42%
-32,179
0.01%
07/31/2018
BNP Paribas Asset Management Belgium SA
401,124
1.34%
0
0.09%
07/31/2018
OppenheimerFunds, Inc.
400,000
1.33%
0
0.01%
03/31/2018
Aviva Investors France SA
356,320
1.19%
0
0.16%
08/31/2018
KBC Asset Management NV
278,025
0.93%
-62,906
0.04%
12/31/2017
| Address |
3, chemin du Cyclotron
Louvain-la-Neuve BU 1348
Belgium
|
|
Employees
|
- |
| Website |
http://www.iba-worldwide.com |
| Updated |
07/08/2019 |
| Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. It operates through the following segments: Proton Therapy and Other Accelerators, and Dosimetry. The Proton Therapy and Other Accelerators segment develops and fabricates medical and industrial particle accelerators and proton therapy systems. |
